Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CABAZITAXEL, with a corresponding US DMF Number 28293.
Remarkably, this DMF maintains an Active status since its submission on June 12, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2014, and payment made on May 20, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II